All terms in CHEBI
| Label | Id | Description |
|---|---|---|
| organic anion | CHEBI_25696 | [Any organic ion with a net negative charge.] |
| alpha-L-Rhap-(1->3)-beta-D-Glcp-(1->4)-alpha-D-GlcpO[CH2]5NH2 | CHEBI_131883 | [A trisaccharide derivative consisting of an alpha-D-glucosyl residue glycosidically linked to a 5-aminopentyl group and which carries at O-4 an alpha-L-rhamnosyl-(1->3)-beta-D-glucosyl disaccharide unit.] |
| calpastatin peptide Ac 184-210 | CHEBI_131884 | [A 27-membered polypeptide comprising the sequence Ac-Asp-Pro-Met-Ser-Ser-Thr-Tyr-Ile-Glu-Glu-Leu-Gly-Lys-Arg-Glu-Val-Thr-Ile-Pro-Pro-Lys-Tyr-Arg-Glu-Leu-Leu-Ala-NH2. An acetylated synthetic peptide from human calpastatin that strongly inhibits both calpains I and II but not papain (a cysteine protease) or trypsin (a serine protease).] |
| EC 3.4.22.53 (calpain-2) inhibitor | CHEBI_82821 | [A calpain inhibitor that interferes with the action of calpain-2 (EC 3.4.22.53).] |
| EC 3.4.22.52 (calpain-1) inhibitor | CHEBI_79050 | [A calpain inhibitor that interferes with the action of calpain-1 (EC 3.4.22.52).] |
| alpha-L-Rhap-(1->3)-beta-D-GlcpO[CH2]5NH2 | CHEBI_131885 | [A disaccharide derivative consisting of a beta-D-glucosyl residue glycosidically linked to a 5-aminopentyl group and which carries at O-3 an alpha-L-rhamnosyl residue.] |
| O-pentadecanoylcarnitine | CHEBI_131886 | [An O-acylcarnitine in which the acyl group is specified as pentadecanoyl.] |
| N-{5-[2-{4-[2-(dimethylamino)ethoxy]phenyl}-4-(pyridin-4-yl)-1H-imidazol-5-yl]-2,3-dihydro-1H-inden-1-ylidene}hydroxylamine | CHEBI_131880 | [A ketoxime that is the oxime of indan-1-one in which the hydrogen at position 5 has been replaced by an imidazol-5-yl group which has itself been substituted at positions 2 and 4 by p-[2-(dimethylamino)ethoxy]phenyl and pyridin-4-yl groups, respectively.] |
| (E)-SB-590885 | CHEBI_131881 | [An N-{5-[2-{4-[2-(dimethylamino)ethoxy]phenyl}-4-(pyridin-4-yl)-1H-imidazol-5-yl]-2,3-dihydro-1H-inden-1-ylidene}hydroxylamine in which the oxime group has E configuration.] |
| SB-590885 | CHEBI_131882 | [A mixture of (E)- and (Z)-SB-590885.] |
| (Z)-SB-590885 | CHEBI_39733 | [An N-{5-[2-{4-[2-(dimethylamino)ethoxy]phenyl}-4-(pyridin-4-yl)-1H-imidazol-5-yl]-2,3-dihydro-1H-inden-1-ylidene}hydroxylamine in which the oxime group has Z configuration.] |
| O-heptadecanoylcarnitine | CHEBI_131887 | [An O-acylcarnitine in which the acyl group is specified as heptadecanoyl.] |
| heptadecanoic acid | CHEBI_32365 | [A C17 saturated fatty acid and trace component of fats in ruminants.] |
| 8-epi-prostaglandin E2 | CHEBI_131888 | [A prostanoid that is prostaglandin E2 having inverted stereochemistry at the 8-position.] |
| bronchoconstrictor agent | CHEBI_50141 | [A drug which causes a narrowing of the lumen of a bronchus or bronchiole.] |
| vasoconstrictor agent | CHEBI_50514 | [Drug used to cause constriction of the blood vessels.] |
| prostaglandin E2 | CHEBI_15551 | [Prostaglandin F2alpha in which the hydroxy group at position 9 has been oxidised to the corresponding ketone. Prostaglandin E2 is the most common and most biologically potent of mammalian prostaglandins.] |
| 11-HEPE | CHEBI_131889 | [A HEPE that consists of (5Z,8Z,12E,14Z,17Z)-icosapentaenoic acid in which the hydroxy group is located at position 11.] |
| all-cis-5,8,11,14,17-icosapentaenoic acid | CHEBI_28364 | [An icosapentaenoic acid having five cis-double bonds at positions 5, 8, 11, 14 and 17.] |
| SL1278 | CHEBI_60093 | [A derivative of alpha,alpha-trehalose having an O-sulfo group at the 2 position and two long chain fatty acyl substituents at the 2'- and 3'-positions.] |